Following a statement from the Swiss competition authority, COMCO, saying it wants to prohibit the Swatch Group from supplying watch mechanisms to other companies during 2020, Swatch, the world’s biggest watch maker, has threatened to pursue damages. “The provisional measures… Read More ›
Swiss
Swiss drugmaker Roche wins U.S. & British approval for its $4.3B acquisition of Spark Therapeutics
Swiss drugmaker Roche has won approval from U.S. antitrust authorities for its $4.3 billion bid to acquire gene therapy specialist Spark Therapeutics. The development clears the way for Roche’s strategic push to position itself in the treatment of rare diseases,… Read More ›
HSBC Holdings Plc’s Swiss unit to pay $192 million in U.S. tax dodging case: DoJ
In a statement the U.S. Department of Justice stated, the Swiss private banking unit of HSBC Holdings Plc will be paying $192.4 million to resolve a U.S. probe of its role in helping wealthy Americans evade taxes by using undeclared… Read More ›
Swiss drugmaker Novartis AG close to acquiring U.S. biotechnology firm The Medicines Co for around $7 billion
According to a report from the Wall Street Journal, Swiss drugmaker Novartis AG is close to clinching an agreement to acquire U.S. biotechnology firm The Medicines Co for around $7 billion. In the potential deal, Novartis has agreed to pay… Read More ›
Little impact on hard Brexit: Nestle’s Europe chief
For Nestle, Britain represents its 5th biggest market. In a significant development, Swiss food giant Nestle’s European chief Marco Settembri disclosed, Brexit will have a “very limited effect” on its British business. “We don’t see any disruption in the business,”… Read More ›
Swiss freight forwarder DSV A/S to acquire Panalpina for $4.62 billion
The development marks the end of a more than two month takeover battle designed to build scale in the consolidating transport sector. On Monday, Swiss freight forwarder DSV A/S disclosed, it will be acquiring Panalpina in a $4.62 billion (4.6… Read More ›
Novartis faces shareholder ire at AGM over skyrocketing drug prices
Shareholders are scheduled to vote on Novartis’s planned spin-off of its Alcon eye care unit. On Thursday, at the annual general meeting of Swiss drugmaker Novartis, shareholders came in heavily at the drugmaker for the hike in drug prices. Novartis… Read More ›
Swiss telecom watchdog faults Swisscom for overcharging
The telecom regulator has reduced prices with retroactive effect for the 2013–2016 period. Swisscom is weighing its decision on filing an appeal with the federal administrative court. In a development that will bring cheers to consumers in Switzerland, the country’s… Read More ›
Swiss pharmaceutical giant Novartis appoints Susanne Schaffert to lead its oncology business
Susanne Schaffert will be replacing Liz Barrett who will return to the U.S. to head a U.S. biotech firm. Swiss pharmaceutical giant Novartis has stated, it has appointed Susanne Schaffert, a veteran, as the head of its oncology business. She… Read More ›
Switzerland’s enters into an era of banking transparency
Swiss authorities have begun sharing account data with countries who meet international requirements on confidentiality and data security. This strategic move has placed Switzerland in fierce competition with fast-growing economies including Singapore and Hong Kong. In a significant development that… Read More ›